NCT04530682Completed
COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs
Seroprevalence and Clinical Expression of SARS-CoV-2 Infection in Patients With Chronic Inflammatory Rheumatisms and Impact of Immuno-suppressive Drugs on the Persistence of Anti-SARS-CoV2 Antibodies During Two Years of Follow-up
Source: ClinicalTrials.gov · Last updated 12 Jun 2026
Brief summary (registry, in English)
Accurate knowledge of the humoral immune responses induced by SARS-CoV-2 in patients undergoing immunosuppressive therapy is essential to guide recommendations for infected patients and for vaccination policy for uninfected immunosuppressed patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 163 (actual)
- First submitted
- 27 Jul 2020
- Start date
- 5 Mar 2021
- Primary completion date
- 23 Jun 2022
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT04530682
What you commit to
- Study type: Observational
- Participants enrolled: 163
- From 5 Mar 2021 to the primary completion date, 23 Jun 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnant or breastfeeding woman
- Refusal to participate in the study
Who the study is looking for
- Patients with rheumatoid arthritis or spondyloarthritis
- With positive serology for SARS-CoV-2 infection less than 3 months old at the time of inclusion
- Under biotherapy, or conventional synthetic Disease-modifying antirheumatic drugs (csDMARD) or Nonsteroidal anti-inflammatory drugs (NSAIDs) or steroids for at least one month during the year 2020
- Agreeement to participate two years in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre hopsitalier universitaire de Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.